×
About 1,037 results

ALLMedicine™ Gastrointestinal Tumors Center

Research & Reviews  509 results

High expression of G protein subunit gamma 13 is associated with poor prognosis of gast...
https://doi.org/10.1016/j.prp.2020.153143
Pathology, Research and Practice; Ju KC, Zhang B et. al.

Aug 27th, 2020 - The G protein subunit gamma 13 (GNG13) plays an important role in olfaction, vision, and biological behavior. However, our knowledge of the relationship between GNG13 expression and the clinicopathological features of gastrointestinal tumors is in...

The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors.
https://doi.org/10.1053/j.semnuclmed.2020.06.003
Seminars in Nuclear Medicine; Halama N, Haberkorn U

Aug 9th, 2020 - New scientific insights in cancer biology and immunobiology have changed the clinical practice of medical oncology in recent years. The molecular stratification of solid tumors has led to improved clinical outcomes and is a key part in the diagnos...

The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors.
https://doi.org/10.1053/j.semnuclmed.2020.06.002
Seminars in Nuclear Medicine; Wahl RL

Aug 9th, 2020 - In the past 20 years there have been great advances in our understanding of the molecular genetics of gastrointestinal tumors. In general, cancers develop and proliferate due to: driver mutations or related alterations in the genome resulting in o...

Cholangiocarcinoma: investigations into pathway-targeted therapies.
https://doi.org/10.1080/14737140.2020.1807333
Expert Review of Anticancer Therapy; Ntanasis-Stathopoulos I, Tsilimigras DI et. al.

Aug 7th, 2020 - Cholangiocarcinoma is a malignant disease of the biliary tract and accounts for 3% of all gastrointestinal tumors. Surgical intervention is currently the only potentially curative strategy for cholangiocarcinoma. For patients with unresectable, ad...

Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targete...
https://doi.org/10.1016/j.radonc.2020.06.041
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology; Reda M, Bagley AF et. al.

Jun 30th, 2020 - Radiation therapy is a cornerstone of modern cancer therapy alongside surgery, chemotherapy, and immunotherapy, with over half of all cancer patients receiving radiation therapy as part of their treatment regimen. Development of novel radiation se...

see more →

Guidelines  1 results

Endoscopic resection of superficial gastrointestinal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977951
World Journal of Gastroenterology; Marc G, Lopes CV

Aug 13th, 2008 - Therapeutic endoscopy plays a major role in the management of gastrointestinal (GI) neoplasia. Its indications can be generalized into four broad categories; to remove or obliterate neoplastic lesion, to palliate malignant obstruction, or to treat...

see more →

Clinicaltrials.gov  523 results

High expression of G protein subunit gamma 13 is associated with poor prognosis of gast...
https://doi.org/10.1016/j.prp.2020.153143
Pathology, Research and Practice; Ju KC, Zhang B et. al.

Aug 27th, 2020 - The G protein subunit gamma 13 (GNG13) plays an important role in olfaction, vision, and biological behavior. However, our knowledge of the relationship between GNG13 expression and the clinicopathological features of gastrointestinal tumors is in...

The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors.
https://doi.org/10.1053/j.semnuclmed.2020.06.003
Seminars in Nuclear Medicine; Halama N, Haberkorn U

Aug 9th, 2020 - New scientific insights in cancer biology and immunobiology have changed the clinical practice of medical oncology in recent years. The molecular stratification of solid tumors has led to improved clinical outcomes and is a key part in the diagnos...

The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors.
https://doi.org/10.1053/j.semnuclmed.2020.06.002
Seminars in Nuclear Medicine; Wahl RL

Aug 9th, 2020 - In the past 20 years there have been great advances in our understanding of the molecular genetics of gastrointestinal tumors. In general, cancers develop and proliferate due to: driver mutations or related alterations in the genome resulting in o...

Cholangiocarcinoma: investigations into pathway-targeted therapies.
https://doi.org/10.1080/14737140.2020.1807333
Expert Review of Anticancer Therapy; Ntanasis-Stathopoulos I, Tsilimigras DI et. al.

Aug 7th, 2020 - Cholangiocarcinoma is a malignant disease of the biliary tract and accounts for 3% of all gastrointestinal tumors. Surgical intervention is currently the only potentially curative strategy for cholangiocarcinoma. For patients with unresectable, ad...

Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targete...
https://doi.org/10.1016/j.radonc.2020.06.041
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology; Reda M, Bagley AF et. al.

Jun 30th, 2020 - Radiation therapy is a cornerstone of modern cancer therapy alongside surgery, chemotherapy, and immunotherapy, with over half of all cancer patients receiving radiation therapy as part of their treatment regimen. Development of novel radiation se...

see more →

News  4 results

Therapeutic endoscopy expands reach to deep GI lesions
https://www.mdedge.com/gihepnews/article/164086/endoscopy/therapeutic-endoscopy-expands-reach-deep-gi-lesions
Michele G. Sullivan, MDedge News

Apr 24th, 2018 - BOSTON – Endoscopic resection of gastrointestinal tumors arising from the muscularis propria is feasible, but the techniques are challenging and require a sure hand with closure techniques. “The main difficulty with these procedures is closure,” M.

FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug
https://www.reuters.com/article/us-lexicon-pharm-fda/fda-approves-lexicon-pharmas-carcinoid-syndrome-diarrhea-drug-idUSKBN1672MV

Feb 28th, 2017 - (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc’s oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors. The drug, Xermelo o...

5 Questions for Josep Tabernero, MD
https://www.onclive.com/publications/oncology-live/2011/october-2011/5-questions-for-josep-tabernero-md

Nov 16th, 2011 - Josep Tabernero, MD Josep Tabernero, MD, is head of the Medical Oncology Department at Vall d’Hebron University Hospital and director of Clinical Research at Vall d’Hebron Institute of Oncology in Barcelona, Spain. He is also the head of the Gastr...

Thalidomide Slows Drastic Weight Loss and Wasting in Pancreatic Cancer Patients
https://www.medpagetoday.com/gastroenterology/pancreaticdiseases/692

Mar 8th, 2005 - Action Points Explain to patients that this is the first controlled study to show significant benefit for thalidomide. Other, large, multicenter studies of thalidomide in pancreatic and other cancers are required before the drug can be considered ...

see more →